Literature DB >> 30834694

Higher visceral fat rate estimated by bioelectrical impedance analysis increases risk for prehypertension in normal weight healthy adults.

Mi-Hyang Jung1, Sang-Hyun Ihm2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30834694      PMCID: PMC8030572          DOI: 10.1111/jch.13507

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  Prehypertension is associated with early complications of atherosclerosis but not with exercise capacity.

Authors:  Mi-Hyang Jung; Sang-Hyun Ihm; Dong-Hyeon Lee; Woo-Baek Chung; Hae Ok Jung; Ho-Joong Youn
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

2.  Greater visceral abdominal fat is associated with a lower probability of conversion of prehypertension to normotension.

Authors:  You-Cheol Hwang; Wilfred Y Fujimoto; Steven E Kahn; Donna L Leonetti; Edward J Boyko
Journal:  J Hypertens       Date:  2017-06       Impact factor: 4.844

3.  The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study.

Authors:  Alvin Chandra; Ian J Neeland; Jarett D Berry; Colby R Ayers; Anand Rohatgi; Sandeep R Das; Amit Khera; Darren K McGuire; James A de Lemos; Aslan T Turer
Journal:  J Am Coll Cardiol       Date:  2014-09-09       Impact factor: 24.094

4.  Higher visceral fat rate estimated by bioelectrical impedance analysis increases risk for prehypertension in normal weight healthy adults.

Authors:  Maja Baretić; Ana Reschner; Ivo Planinc
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-04       Impact factor: 3.738

5.  Prehypertension is a comorbid state with autonomic and metabolic dysfunction.

Authors:  Mi-Hyang Jung; Sang-Hyun Ihm; Dong-Hyeon Lee; Young Choi; Woo-Baek Chung; Hae Ok Jung; Kyung-Soon Hong; Ho-Joong Youn
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-06       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.